article thumbnail

Researchers reverse the in vitro and in vivo effects of the mutation that causes Stormorken syndrome

Medical Xpress

That was the case when Thilini Gamage was to carry out one of the studies in her doctoral work with Professor Eirik Frengen at the Institute of Clinical Medicine, University of Oslo. They study gene variation and mutations that cause rare genetic diseases. A mutation is a permanent change in the genetic material.

article thumbnail

A Unique Approach to in vivo CAR T Therapy and New Advancements in the Field

XTalks

He then completed post-doctoral studies at Penn State developing chimeric papillomavirus vaccines. Tune into the episode to learn more about the promise of in vivo CAR T therapy and novel advancements in the field. Their lead program focuses on an intravenous CAR therapy for B cell lymphomas.

In-Vivo 59
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Gene editing: beyond the hype

pharmaphorum

This has, of course, garnered immense excitement – Doctors Emmanuelle Charpentier and Jennifer Doudna were named winners of the Nobel Prize for chemistry in recognition of their discovery of CRISPR/Cas9 gene editing technology. Zinc fingers. Macrae had previously worked at GSK and Takeda before he was recruited by Sangamo.

article thumbnail

Katie Porter attacks pharma

World of DTC Marketing

Ex vivo (where cells are genetically modified outside the body) cell and gene therapies have generated considerable excitement on their potential to cure previously incurable diseases. Still, she is missing a lot of facts at a time when hospital and health insurance costs are soaring. In pharma R&D returns have declined to 1.8

In-Vivo 187
article thumbnail

Gulf War Illness: How can disease modelling aid the search for a cure?

pharmaphorum

Disease modelling Gulf War Illness. In the mid-to-late 1990s, an unexplained illness began to emerge in army bases across the US. Symptoms and their severity ranged across individuals, and included fatigue, musculoskeletal pain, skin rashes, headaches, and gastrointestinal issues. Tinker, tailor, soldier, therapy.

In-Vivo 98
article thumbnail

Boehringer recruits former Novartis’ neurosciences head as its CMO

pharmaphorum

She has also held senior positions at Roche, Novo Nordisk, and Lundbeck, and trained as a medical doctor in Denmark before completing an MBA in Switzerland. “It’s so exciting to be part of this company as we share our passion to deliver innovative medicines to patients faster,” she said in a LinkedIn post.

In-Vivo 59
article thumbnail

Dr. Kent R. Van Kampen Celebrated for Dedication to the Field of Pharmaceutical Research

The Pharma Data

Before embarking on his professional journey, in 1961, Dr. Van Kampen earned a Bachelor degree in Veterinary Science from Utah State University, in 1964, a Doctorate of Veterinary Medicine from Colorado State University, and in 1967, a Doctorate of Philosophy in Comparative Pathology from the University of California at Davis in 1967.